Dexmedetomidine infusion for sedation of a patient with multiple system atrophy during spinal anesthesia

  • Satoko Kinouchi Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, (Japan)
  • Yoshie Onishi Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, (Japan)
  • Luna Nishihara Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, (Japan)
  • Toshiki Okada Department of Anesthesiology, Minoh City Hospital, 5-7-1 Kayano, Mino-shi, Osaka, (Japan)
Keywords: Multiple system atrophy, Dexmedetomidine, Spinal anesthesia

Abstract

Multiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by extra-pyramidal symptoms, cerebellar ataxia, and autonomic dysfunction. The perioperative management of patients with MSA is challenging primarily due to autonomic dysfunction and vocal cord paralysis. Dexmedetomidine (DEX) is a highly selective a2-adrenoreceptor agonist that is used as a sedative, causing minimal depression of the respiratory function. We administered DEX continuously for sedation during spinal anesthesia for bipolar hip arthroplasty in a patient with MSA, without any cardiovascular or respiratory complications. This is the first case report of the efficacy of DEX for the sedation of a patient with MSA during spinal anesthesia

Published
01-16-2019
How to Cite
Kinouchi, S., Onishi, Y., Nishihara, L., & Okada, T. (2019). Dexmedetomidine infusion for sedation of a patient with multiple system atrophy during spinal anesthesia. Anaesthesia, Pain & Intensive Care, 22(1), 122-124. Retrieved from https://apicareonline.com/index.php/APIC/article/view/8
Section
Case Reports